"TIL content was not associated with survival in patients who were NOT treated with immunotherapy." -- Cancer Immunol Res link
What will potentially occur to placebo patients upon crossover to DCVax-L assuming the vaccine isn't a placebo? Answer: A correlation between TIL content and OS may exist with immunotherapy.